Cardiosense
PrivateLast Round
Series B
Aug 7, 2026
Total Funding Raised
$17.7M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Cardiosense operates in Healthcare & Life Sciences and is based in Chicago, Illinois. Its latest recorded funding round was a VC Round in April 2026.
Cardiosense is a digital health company that develops a physiological waveform AI platform and multi-sensor devices to enable early detection and management of cardiovascular disease.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Medical AI, Health IoT, Healthcare Analytics, Clinical Trials
Business Model
B2B2C
Customer Profile
Hardware + Subscription, Subscription SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cardiosense Comparables
Compare Cardiosense with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Nanowear | 85% | |
| BioIntelliSense | 82% | |
| Bodyport | 81% |
For institutional investors. Book with your work email.
Cardiosense Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Aug 7, 2026 | ||||
| VC Round | Apr 1, 2026 | ||||
| Series A | Dec 8, 2022 | ||||
| Seed | Jun 1, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Cardiosense Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| UnityPoint Health Ventures | Series A |
| Hatteras Venture Partners | Series B, Series A |
| OSF Ventures | Series A |
| Cross Border Impact Ventures | Series A |
| Oakwood Circle Ventures | VC Round |
| Chevron Technology Ventures | Seed |
| Portal Innovations | Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 17, 2026
Open roles increased to 50, 2.1x the trailing average.
- Aug 7, 2026
$26M round completed.
For institutional investors. Book with your work email.
Cardiosense Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Cardiosense's valuation, stock price, and market status.
Is Cardiosense a public or private company?
Cardiosense is a private company.
What is the current stock price of Cardiosense?
Cardiosense is a private company, so its shares have no public market price. Caplight tracks Cardiosense's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Cardiosense worth (valuation)?
Valuation information for Cardiosense is not publicly available.
Can I buy Cardiosense stock?
Cardiosense shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Cardiosense's last funding round?
Cardiosense's most recent funding round was Series B on August 7, 2026.
Who are the main investors in Cardiosense?
Key investors in Cardiosense include Hatteras Venture Partners, Broadview Ventures.
Will Cardiosense IPO soon?
No public IPO plans have been announced for Cardiosense.
How can I track Cardiosense secondary market activity?
Caplight tracks bids, offers, and trades in Cardiosense's shares on secondary markets.